Invest in your brain health

Play a part in developing predictive algorithms for epilepsy, Alzheimer’s, and Parkinson’s disease.

This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For risks relating to this offering, see the Subscription Agreement for this offering.

Invest Now

The Importance of Sanitary, Disposable NeuroCap

A recent report indicated that more than one-third of coronavirus patients had some type of neurologic symptom. Neurologists and other medical practitioners are urged to follow sanitary techniques to avoid spreading COVID-19 through cross-contamination.

We believe that disposable EEG headset NeuroCap can help flatten the Covid-19 curve.

Why Invest?

Brain Scientific’s mission is to develop algorithms to detect neurological disorders, including epilepsy, memory dementia, and pre-Alzheimer’s diagnosis.

Neurological disorders are increasingly recognized as major causes of death and disability worldwide. More than 50 million people have epilepsy worldwide.

It is estimated that this number will almost double

World Health Organization, 2020

Invest Now

Our first commercialized products, NeuroCap and NeuroEEG, aim to disrupt the expensive EEG market with economic and disposable substitutes that permit any medical professional in any setting to diagnose patients remotely within minutes.

We want to improve patient access to neurological care and provide analysis through artificial intelligence (AI) to improve diagnosis. To achieve this, we plan  to create a database of normal and abnormal brains for detecting seizures and dementia, and AI and machine learning processes will help detect
abnormal activity.

Market Demand

The brain monitoring industry is composed of smaller markets that aim to understand, diagnose, treat, and cure mental conditions. These emerging industries account for a majority of the growth in the brain monitoring industry, and drive the need for improved brain monitoring technology.

Neurological Condition and Number
of Diagnosed Individuals

Alzheimer’s disease

40 million

Sports-related head injuries

446,788 (US Only)

Depression

350 million

Epilepsy

50 million

ADHD

6.4 million

Stroke

795,000 (per year)

Sleep disorders

150 million

Dementia

47.5 million

Migraine

37 million

DOWNLOAD OUR PRESENTATION

Here is
the math

Alzheimer’s

Someone in the world develops
dementia every 3 seconds.

It is estimated that globally there are 47.5
million people with dementia, with 7.7
million new cases every year. Alzheimer's
disease is the most common cause of
dementia and may contribute to 60–70%
of cases.

Epilepsy

Around 50 million
people worldwide have epilepsy,
making it one of the most
common neurological
diseases globally.

Nearly 80% of people with epilepsy live in
low- and middle-income countries. It is
estimated that up to 70% of people living
with epilepsy could live seizure-free if
properly diagnosed and treated.

About 1% of Americans
have some form
of epilepsy, and nearly
4% (1 in 26) will develop
epilepsy at some point in
their lives.

The number of Americans who have
epilepsy is greater than the number
who have multiple sclerosis, Parkinson's
disease, and cerebral palsy combined.

Successes

Brain Scientific has developed two EEG devices to streamline EEG application and diagnosis:

NeuroCap, a disposable EEG headset with 22 pre-gelled electrodes following the international 10–20 system, and NeuroEEG, a portable wireless EEG amplifier that is smaller than a deck of playing cards.
Brain Scientific has received FDA 510(k) clearance for NeuroCap and NeuroEEG in 2018
Successful early adopters program for NeuroCap and NeuroEEG (2018—2019)

Partner with industry leaders in EEG manufacturing and distributors to service national and global EEG market in progress
In 2018—2019, Brain Scientific has presented the company’s technology and devices at international and American conferences and trade shows

including American Epilepsy Society (AES) Annual meetings, ASET, ACNS.

Invest Now

Brain Scientific’s project on graphene EEG electrodes was chosen by Epilepsy Foundation for 2020 Shark Tank Competition Five Finalists

Shark Tank Competition

Testimonials

Our products are already operating across the
country and have received good reviews

Dr. John Gaitanis

Chief of Pediatric Neurology at Tufts Medical Center:

«With Brain Scientific EEG technology, a telemedicine physician could ask the emergency room staff to start the EEG, and they can read it in real-time...»

Dr. Gaitanis is a medical advisor of Brain Scientific